Abstract:The influences of mixing time, manufacturing stage, and sample size on the evaluation of content uniformity in low dose direct compression blends and their corresponding tablets were studied. A high speed stationary shell mixer was used to blend 16 l-kg batches of a direct compression low dose formulation containing 0.1% theophylline, 99.4% microcrystalline cellulose (Avice® PH-200), and 0.5% magnesium stearate. Batches were mixed for 1 or 60 min. Numerous powder samples and compressed tablets were tested for USP XXII Uniformity of Dosage Units. From each batch, 100 dose units divided into 10 groups of 10 were individually assayed. At 1-min mixing the mean percent label claim of the tablets was significantly different from the powder samples (p≤0.0001). For the tablets the percent label claim ranged from 58-350% and the % relative standard deviations (RSDs) ranged from 3-79%. However, the percent label claim of the powder samples ranged from 31-113%, with % RSDs ranging from 4-54%. At the 60-min mixing time the difference between the mean % label content of the tablets and powder samples was also significant (p≤0.0001). For tablets, percent label claim ranged between 40 and 113%, with % RSDs ranging from 17-36%, while for the powders, the percent label claim ranged from 8-563% and the % RSD range was 24-119%. A maximum 3.75% relative standard deviation of tablet weight was found among the 90 groups assayed. Although the results were outside the USP test acceptable limits, the content uniformity of the tablets was significantly different to that of powder samples at both mixing times. The results indicate that the content uniformity of powder samples collected prior to tabletting is not a suitable indicator of the finished product content uniformity. The results of the content uniformity statistical analysis suggUSP test may be inadequate. There is an urgent need to re-evaluate USP test for Uniformity of Dosage Units in relationship to the percent drug content in the tablet and the therapeutic index of the drug

Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.

Study of compaction tools and parameters on critical quality attributes of high drug load minitablets

The effect of excipient particle size on the reduction of compactibility after roller compaction

Small-Scale Modeling of Pharmaceutical Powder Compression from Tap Density Testers, to Roller Compactors, and to the Tablet Press Using Big Data

Concomitant and repeated happenings of complications of the third stage of labour

Microbial Carbonate Precipitation by Urease Producing Bacteria in Cementitious Materials

Functional disability in residents of Auckland rest homes.

Development of a Robust Control Strategy for Fixed-Dose Combination Bilayer Tablets with Integrated Quality by Design, Statistical, and Process Analytical Technology Approach

A modified Kushner-Moore approach to characterising small-scale blender performance impact on tablet compaction

Material-Sparing Approach to Predict Tablet Capping Under Processing Compression Conditions Based on Mechanical and Molecular Properties Derived from Compaction Simulation and Crystal Structural Analysis

Quantification of lubrication and particle size distribution effects on tensile strength and stiffness of tablets

Influence of Process Parameters on Content Uniformity of a Low Dose Active Pharmaceutical Ingredient in a Tablet Formulation According to GMP

Impact of Mixing on Content Uniformity of Thin Polymer Films Containing Drug Micro-Doses

Optimization of a Twin screw melt granulation process for fixed dose combination immediate release Tablets: Differential amorphization of one drug and crystalline continuance in the other

Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects

Evaluation of the Potential of Novel Co-Processed Excipients to Enable Direct Compression and Modified Release of Ibuprofen

Studies on the Influence of High-Shear Granulation Process on the Compressibility of Microcrystalline Cellulose

The effect of some binding agents on the mechanical properties of granules and their compression characteristics

Preliminary investigations of the suitability of the USP uniformity of dosage units tests for evaluating the uniformity of powder blends and their corresponding tablets

The Effect of Microcrystalline Cellulose–CaHPO4 Mixtures in Different Volume Ratios on the Compaction and Structural–Mechanical Properties of Tablets